original ) (raw )Miscellaneous Ethylenedicysteine Versus Diethylenetriamine Pentaacetic Acid as the Carrier of Technetium Tc 99m in Diuretic Renography for Patients with Upper Urinary Tract Obstruction
Sepideh Hekmat
2006
View PDFchevron_right
Technetium-99m-N,N-Ethylenedicysteineâ€"A Comparative Study of Renal Scintigraphywith Technetium-99m-MAG3and Iodine-131-OIHin Patients with Obstructive Renal Disease
Kutlan Özker
1994
View PDFchevron_right
Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease
Haluk B . Sayman , Kutlan Özker
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994
View PDFchevron_right
Technetium99mL,L-Ethylenedicysteine Is More Effective Than Technetium99m Diethylenetriamine Penta-acetic Acid for Excluding Obstruction in Patients With Pyelocalicinal Dilation
Mariana Lima
Urology, 2010
View PDFchevron_right
Estimation of absolute renal uptake with technetium-99m dimercaptosuccinic acid: direct comparison with the radioactivity of nephrectomy specimens
Celso Ramos
Sao Paulo Medical Journal, 2008
View PDFchevron_right
Comparison of radionuclide estimation of glomerular filtration rate using technetium 99m diethylenetriaminepentaacetic acid and chromium 51 ethylenediaminetetraacetic acid
John Fleming
European Journal of Nuclear Medicine, 1991
View PDFchevron_right
Evaluation of technetium-99m-ethylenedicysteine in renal disorders and determination of extraction ratio
vural vural
The Journal of nuclear …, 1995
View PDFchevron_right
Değerlendirme technetium-99m-ethylenedicysteine, renal bozukluklar ve tayini (ekstraksiyon oranı
Ali Kerim
The Journal of nuclear …, 1995
View PDFchevron_right
The Role of Time to Half-Maximum Activity Clearance of Technetium-99m- Mercaptoacetyltriglycine in the Assessment of Obstructive Uropathy
suliman salih
BMC Nuclear Medicine
View PDFchevron_right
Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders
Turgut Turoglu
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995
View PDFchevron_right
Fahmy HM, Yassin HM, Muhammed IM, Mohamed SE, Hassan SS. Evaluation of the Efficiency of 99mTc-DMSA as a Radiopharmaceutical in Dynamic Renal Scans. Erciyes Med J 2018; 40(3): 140-7.
Journal of Clinical Practice and Research
Erciyes Medical Journal, 2018
View PDFchevron_right
Renal handling of technetium-99m DMSA: evidence for glomerular filtration and peritubular uptake
J. Kosterink
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1989
View PDFchevron_right
Preliminary assessment of interand intraobserver reproducibility, and normative values of renal mean transit time (MTT) and parenchymal transit time (PTT) for 99mTc-etylenodicysteine
Malgorzata Bienkiewicz
Nuclear Medicine Review, 2015
View PDFchevron_right
Is furosemide administration effective in improving the accuracy of determination of differential renal function by means of technetium-99m DMSA in patients with hydronephrosis
Ozlem Ozmen
European Journal of Nuclear Medicine and Molecular Imaging, 2002
View PDFchevron_right
Renal arteriovenous transit times of technetium-radiolabeled chelates
Carl Wesolowski
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1987
View PDFchevron_right
Formulation and evaluation of a single vial lyophilized preparation of technetium-99m labeled ethylene dicysteine as a renal scintigraphic agent
Shabana Saeed
Pakistan journal of pharmaceutical sciences, 2014
View PDFchevron_right
Technetium thiodiglycollic acid ( 99m Tc-TDG). A new radiopharmaceutical with the potential for the assessment of renal function
david Nowotnik
European Journal of Nuclear Medicine, 1985
View PDFchevron_right
Quantitative technetium-99M dimercaptosuccinic acid renal scanning in children
George Steinhardt
Urology, 1996
View PDFchevron_right
Comparison of differential renal function using technetium-99m mercaptoacetyltriglycine (MAG3) and technetium-99m dimercaptosuccinic acid (DMSA) renography in a paediatric population
Robin Prescott
Pediatric Radiology, 2008
View PDFchevron_right
Technetium-99m-N,N-ethylenedicysteine and Tc-99m DMSA scintigraphy in the evaluation of renal parenchymal abnormalities in children
Ali Anarat , Mustafa Kibar
Annals of Nuclear Medicine, 2003
View PDFchevron_right
Technetium-99m-dimethylglyoxime (99mTc-DMG) as renal imaging agent
Viviana Adonaylo
Journal of Labelled Compounds and Radiopharmaceuticals, 1993
View PDFchevron_right
Evaluation of 99mTc- MAG3/DTPA Radiopharmaceuticals in Detection of Hydronephrosis
suliman salih
Life Science Journal
View PDFchevron_right
Reassessment of the reproducibility of Technetium-99m mercaptoacetyltriglycine renal clearance
Marianne Tondeur
2005
View PDFchevron_right
Renal output efficiency and normalized residual activity examined by technetium-99m-DTPA renography have by far greater specificity to diagnose obstructive disease as compared to other conventional parameters of the renogram. First such study of output efficiency
Dragana Sobic Saranovic
Hellenic journal of nuclear medicine, 2018
View PDFchevron_right
Original Reassessment of the reproducibility of Technetium-99m mercaptoacetyltriglycine renal clearance
Marianne Tondeur
2016
View PDFchevron_right
Measurement of Glomerular Filtration Rate with Technetium-99m DTPA: Comparison of Plasma Clearance Techniques
John Fleming
Journal of Nuclear Medicine, 1987
View PDFchevron_right
U.se of Technetium99m-MAG3 for Renal Scantigraphy After Angiotensin-Converting Enzyme Inhibition
Stefano Fanti
2000
View PDFchevron_right